Open AccessBiobridge: An Outlook on Translational Bioinks for 3D Bioprinting (Adv. Sci. 3/2022)
Author(s) -
Gu Yawei,
Forget Aurelien,
Shastri V. Prasad
Publication year - 2022
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.202270018
Subject(s) - bench to bedside , 3d bioprinting , regenerative medicine , translational medicine , nanotechnology , computer science , engineering , biomedical engineering , tissue engineering , medicine , biology , materials science , stem cell , medical physics , microbiology and biotechnology , pathology
Translational Bioinks for 3D Bioprinting 3D‐Bioprinting, a technology at the interface of additive manufacturing, biomaterials and cell biology, is poised to revolutionize regenerative medicine and drug screening. Bioinks are the lynchpin as they bridge bench to bedside. A biology‐based approach to engineering bioinks with pro‐regenerative attributes, with an emphasis on reproducibility, efficiency, and conformance to regulatory standards is essential for paving the way to clinical translation. More details can be found in article number 2103469 by V. Prasad Shastri and co‐workers.